Certified by Founder Lodge
Lightstone Ventures
United States - Menlo Park, CA
INVESTOR
1 Disclosed Funding Rounds $37,900,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Lightstone Ventures is a global venture capital fund dedicated to translating novel scientific breakthroughs into clinically and commercially meaningful therapies. We invest in biotech and me
| Company | Date | Round | Raised |
|---|---|---|---|
 Allay Therapeutics |
June, 06 ,2025 | Series D | $57,500,000 |
 Relievant Medsystems, Inc. |
April, 21 ,2023 | Unknown | $50,000,000 |
 Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
 Reprieve Cardiovascular |
February, 21 ,2024 | Series A | $42,000,000 |
 Alchemab Therapeutics Ltd |
September, 10 ,2025 | Series A | |
 Cerevance |
April, 26 ,2024 | Series B | $47,000,000 |
 Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
 Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Allay Therapeutics |
June, 06 ,2025 | Series D | $57,500,000 |
| Apreo Health |
August, 12 ,2025 | Series B | $130,000,000 |
| Alchemab Therapeutics Ltd |
September, 10 ,2025 | Series A | |
| Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
